Dermatology
Skin clinical trials
Psoriasis, eczema, skin cancers, and other conditions of the skin and connective tissue. We’re tracking 5,022 recruiting studies in this area right now.
By phase
- Not applicable2,809
- Phase 2751
- Phase 1522
- Phase 3382
- Phase 1/Phase 2295
- Phase 4204
- Phase 2/Phase 359
Top conditions
- Breast Cancer1,192
- Melanoma174
- Metastatic Breast Cancer138
- Rheumatoid Arthritis131
- Atopic Dermatitis124
- Systemic Lupus Erythematosus119
- Breast Neoplasms111
- Triple Negative Breast Cancer111
- Colorectal Cancer93
- Ovarian Cancer91
- Psoriasis85
- Breast Carcinoma79
- Lung Cancer77
- Prostate Cancer69
- Rheumatoid Arthritis (RA)68
- Diabetic Foot Ulcer59
- Cancer58
- Systemic Lupus Erythematosus (SLE)52
Leading sponsors
- Fudan University64
- M.D. Anderson Cancer Center51
- Novartis Pharmaceuticals49
- Memorial Sloan Kettering Cancer Center48
- Mayo Clinic40
- AstraZeneca38
- Assistance Publique - Hôpitaux de Paris37
- National Cancer Institute (NCI)37
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University34
- Second Affiliated Hospital, Zhejiang University, School of Medicine30
Where studies are running
- California407
- Arizona150
- Alabama129
- Florida126
- New York110
- Texas106
- Maryland94
- Massachusetts87
- Pennsylvania72
- North Carolina68
Recruiting studies5,022 total
- NCT06636981RecruitingPhase 2
Combination therapy for advanced triple negative breast cancer
This trial tests a new combination of a vitamin A derivative (all-trans retinoic acid), an immunotherapy drug (toripalimab), and chemotherapy for people with advanced triple negative breast cancer that cannot be removed by surgery or has spread. The goal is to see if this combination helps shrink or control the cancer better than current treatments.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07564154RecruitingPhase 1
Testing KT502 injections for active rheumatoid arthritis
This is an early-stage study testing a new injectable treatment called KT502 for people with moderate-to-severe rheumatoid arthritis (RA) that hasn't responded well to standard treatments. The study will check if the medication is safe and how the body responds to it.
Bayswater, VictoriaAges 18–75 - NCT07563595Recruiting
Elacestrant for advanced ER+ HER2- breast cancer with ESR1 mutation
This trial tests elacestrant, a new hormone therapy drug, in women whose advanced or spread breast cancer has stopped responding to first-line hormone treatment. The drug is designed to work against a specific genetic change (ESR1 mutation) that can develop in these cancers.
Freiburg im BreisgauAges 18 years+ - NCT07567131Recruiting
Understanding sun sensitivity in rare porphyria disorders
This study tracks how your body reacts to sunlight if you have erythropoietic protoporphyria (EPP) or X-linked protoporphyria (XLP)—rare genetic conditions that cause painful skin reactions to sun exposure. Researchers will use special devices and daily logs to better understand your symptoms and how light affects your skin.
Boston, MassachusettsAges 12 years+ - NCT07560618RecruitingPhase 4
Testing a new cream for itch relief in atopic dermatitis
This study tests whether roflumilast cream (a new anti-inflammatory medication applied to the skin) can reduce the intense itching caused by atopic dermatitis (eczema). You'll track your itching daily using a smartphone app and visit the clinic to see if the cream helps over time.
Sacramento, CaliforniaAges 12 years+ - NCT07565506RecruitingPhase 2
Nu-3 Gel for Mild Diabetic Foot Infections
This study tests a new gel treatment (Nu-3) for mild infections in diabetic foot ulcers. The goal is to find the right dose and see if it helps heal these wounds safely.
Los Angeles, CaliforniaAges 18 years+ - NCT07561242Recruiting
Skin response to fractional laser treatments in darker skin tones
This study measures how skin changes after two types of laser treatments (gentler and stronger) on the forearm. Researchers want to understand how these lasers work on darker skin types to improve safety and results.
Shanghai, Shanghai MunicipalityAges 18–60 - NCT07565285RecruitingPhase 2
Combination Treatment for Operable Stage III Skin Melanoma
This study tests whether combining a new drug called PRTX007-003 with pembrolizumab (an immunotherapy) can help prevent melanoma from returning after surgery. You would receive both treatments after your tumor is surgically removed.
Waratah, New South WalesAges 18 years+ - NCT05017142Recruiting
Pediatric brain inflammation registry for Swiss patients
This study is a registry that collects health information from children and teens in Switzerland diagnosed with certain inflammatory brain and spinal cord conditions. It helps researchers understand these illnesses better over time and may guide future treatments.
Aarau, Canton of AargauAges Up to 36 years - NCT03116412Recruiting
Imaging check-ups after melanoma surgery trial
This trial studies whether adding or adjusting imaging scans during follow-up after melanoma surgery can help detect recurrence earlier. It compares different follow-up imaging schedules for people at higher risk after surgery.
BoråsAges 18 years+ - NCT04170634Recruiting
CT scan study to assess bone strength in certain cancers
This study uses a CT scan to estimate how strong a cancer-affected bone area is, helping doctors evaluate fracture risk and bone management. It is aimed at adults with bone lesions from several common cancer types.
AngersAges 18 years+ - NCT02954939Recruiting
Test medicines to change immune cells in lupus kidney flare
This study tests whether mycophenolate mofetil and cyclophosphamide can improve active lupus kidney inflammation by changing immune cell patterns in your blood. It may help patients whose lupus nephritis is currently active, shown by worsening urine protein and/or kidney blood tests.
Hong KongAges 18–80 - NCT04661501Recruiting
Trial of special breast skin graft in implant reconstruction
This trial studies whether a lab-made skin graft (called ADM) used with tissue expanders can improve breast reconstruction after mastectomy. It may help people who are planning a specific two-step implant reconstruction approach.
Vancouver, British ColumbiaAges 21–65 - NCT06155604RecruitingPhase 2
SGLT2 inhibitor for lupus nephritis with kidney disease
This study tests if an SGLT2 inhibitor can help protect kidney function in people who have lupus nephritis (kidney inflammation caused by lupus) and chronic kidney disease (CKD). The goal is to see if this medicine can slow down further kidney damage.
Hong KongAges 18 years+ - NCT07566871Enrolling by invitation
Nerve Stimulation to Help Burn Injury Recovery
This study tests whether gentle electrical stimulation of a nerve in your ear can help reduce anxiety, improve sleep, and ease pain or itching after a burn injury heals. You would wear a small device on your ear for several weeks.
Istanbul, KartalAges 18–65 - NCT07559877RecruitingPhase 3
Chlorhexidine spray to prevent radiation skin damage in throat cancer
This study tests whether a chlorhexidine spray (an antiseptic liquid) can prevent or reduce skin damage caused by radiation therapy in people being treated for nasopharyngeal cancer (cancer in the back of the nose/throat). Radiation dermatitis—painful redness and irritation of the skin—is a common side effect, and this spray may help protect your skin during treatment.
Nanchang, JiangxiAges 18–75 - NCT07565350Recruiting
Heat and hydrogen peroxide for stubborn viral warts
This trial tests combining local heat therapy with a hydrogen peroxide solution to treat viral warts that haven't responded to other treatments like freezing or lasers. The goal is to find a new option for people frustrated by warts that keep coming back.
Shenyang, LiaoningAges Any age - NCT07564570Recruiting
Exercise Before Melanoma Immunotherapy Treatment
This study tests whether doing physical exercise right before receiving immunotherapy (two drugs called nivolumab and ipilimumab) helps treat advanced melanoma. The goal is to see if exercise boosts how well these cancer-fighting drugs work in your body.
Hamburg, Free and Hanseatic City of HamburgAges Any age - NCT07561580Recruiting
Botulinum toxin for excessive forehead sweating
This trial tests whether botulinum toxin injections can reduce excessive sweating on the forehead. If your forehead sweats heavily despite using antiperspirants, this treatment might help you stay dry and more comfortable.
LatakiaAges 18–40 - NCT07566351RecruitingPhase 2
Add-On Drugs for Rheumatoid Arthritis
This study tests whether two drugs—roflumilast and desloratadine—added to your current rheumatoid arthritis medications can reduce joint inflammation and pain. You'd take these as add-ons to your existing treatment to see if they help control your disease better.
Damietta, Damietta GovernorateAges 18–60 - NCT07566923Enrolling by invitation
Vagus Nerve Stimulation for Teen Burn Recovery
This study tests a non-invasive device placed on the ear that stimulates the vagus nerve (a major nerve that affects stress and healing) to help adolescents recovering from burns feel less anxious, sleep better, and experience less pain and itching. The device is worn on the outside of the ear and may help your body heal.
Istanbul, KartalAges 12–18 - NCT07563036Recruiting
JAK2 Protein Changes in Male Pattern Baldness With Minoxidil
This study examines how a protein called JAK2 changes in the scalp when men with male pattern baldness use minoxidil (Rogaine), a common hair-loss treatment. Understanding this might help explain why minoxidil works and improve future treatments.
Cairo, Cairo GovernorateAges 18–50 - NCT07562841RecruitingPhase 1
Gold nanoparticles and radiation therapy for advanced melanoma
This study tests a new treatment combining gold nanoparticles (Au-TMP), radiation therapy, and an immune-boosting drug (anti-PD-1) for advanced melanoma that cannot be surgically removed. The goal is to help your immune system fight the cancer more effectively.
Chengdu, SichuanAges 18 years+ - NCT07563621Recruiting
Understanding Vaginal Health Changes in Breast Cancer Survivors
This study examines vaginal dryness and discomfort—common side effects of breast cancer treatment—in women who've survived the disease. Researchers want to understand how often this happens and how much it affects daily life, which may help doctors better support survivors.
Hasselt, LimburgAges 18 years+
Common questions
- How many skin clinical trials are recruiting?
- Clin2 is tracking 5,022 recruiting dermatology studies from the U.S. registry right now, out of 7,792 we cover in this area in total.
- What does “Skin” cover here?
- Psoriasis, eczema, skin cancers, and other conditions of the skin and connective tissue. We group each study into skin based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a skin trial near me?
- Use the search to filter skin studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Cancer
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Blood & lymphatic
- Kidney & urinary
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.